|
|
NEW ON THE MARKET
|
|
Propranolol (HEMANGIOL) for infantile hemangioma
GLP-1 receptor agonist dulaglutide (TRULICITY) for type 2 diabetes
VIEKIRAX plus dasabuvir (EXVIERA) - multiple combination therapy against hepatitis C
|
|
|
THERAPY FROM A CRITICAL VIEWPOINT
|
|
GRAZAX and ORALAIR: sublingual immunotherapy for grass pollen allergy
|
|
|
BEWARE MISINFORMATION
|
|
Emergency contraception: scientific associations' criticism about non-prescription status is baseless
|
|
|
CURRENT ADR NETWORK REPORT
|
|
Liver damage due to IBEROGAST?
|
|
|
SIDE EFFECTS
|
|
EMA, FDA: cardiovascular safety of testosterone (e.g. NEBIDO) not established
|
|
|
e a-t IN INTERNET
|
|
Varenicline (CHAMPIX): decreased tolerance to alcohol, seizures etc.
|
|